Samyang Holdings implements various partnership models such as joint and sponsored research and development, licensing in/out, M&A, investment, and joint venture to develop therapeutics using SENS™, our unique gene delivery technology.

• Companies or academia, research or other related institutes that have nucleic-acid-based vaccine and gene therapy technologies

• Companies or academia, research or other related institutes that have new polymers and lipids

• Companies or academia, research or other related institutes with expertise in process development